Biotech Values

[WorstLuck]

I don't think there is anything in the advanced Enanta pipeline that is worthy of an acquisition

I agree. There is some chance that RSV pans out. It feels more likely that they run another P2 (or two) with 323/combo before giving up. There are shots on goal but...

As pointed out, the solution is to simply not invest. The problem for me, as well as a lot of other people, is that we're already invested in what seemed like a decent investment with recurring revenue and multiple shots on goal most of which have now fallen by the wayside.

If you weren't already an investor, would you buy at these levels? I understand there are tax implications and so on... but it's a good question to ask.

What I think Jay Luly lacks is a vision

I think his vision just doesn't match up well with my views as an investor. The strategic approach is another thing I don't like as an investor. For someone else they may be fine.

Thanks for the thoughtful views. Understanding where someone else stands is a big thing.